Travere Therapeutics, Inc. TVTX
49.70 USD +0.29 (+0.59%)
Nov 4, 2026, 9:46 AM EST
49.55 Day range 50.65
22.59 52-week range 68.73
- YTD
- +30.07%
- 1 year
- +45.62%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 75.14 +51.2% upside
Now 49.70
- Target (low)
- 62.00
- Target (mean)
- 75.14
- Target (high)
- 90.00
Ratings (0m) 15 14 buy · 1 hold · 0 sell
- Strong buy2
- Buy12
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 15
- 2 months ago 15
- 3 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.90141 | -0.57108 – 1.22 | 0.37 | +143.6% | 243.04M | +87.4% | 8 |
| Next quarter | 1.05 | 0.73 – 1.27 | 0.37 | +184.9% | 247.11M | +94.3% | 8 |
| Current year | 0.33 | 0.33 – 0.33 | 0.91 | -63.7% | 766.24M | +56.1% | 1 |
| Next year | 5.35 | 3.50 – 6.76 | 0.33 | +1521.9% | 1.09B | +42.3% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 24, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 22, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Sep 22, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 10, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 6, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 5, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 5, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 5, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jun 25, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 22, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Jun 18, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jun 15, 2026 | Citigroup | Maintained | Buy | Buy |
| Jun 12, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jun 3, 2026 | Citigroup | Maintained | Buy | Buy |
| Jun 3, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Jun 2, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 6, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 5, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 5, 2026 | Citigroup | Maintained | Buy | Buy |
| May 5, 2026 | Wedbush | Maintained | Outperform | Outperform |
| May 5, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 24, 2026 | Guggenheim | Maintained | Buy | Buy |
| Apr 14, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 14, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 14, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Apr 14, 2026 | Guggenheim | Maintained | Buy | Buy |
| Apr 14, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
